Home
/
CARDINAL HEALTH INC
/
Financials
/
Quarterly
CARDINAL HEALTH INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CARDINAL HEALTH INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$65.63B
Feb 5, 2026
Q1
2026
Sep 30, 2025
$64.01B
Oct 30, 2025
Q3
2025
Mar 31, 2025
$54.88B
May 1, 2025
Q2
2026
Dec 31, 2024
$55.26B
Feb 5, 2026
Q1
2026
Sep 30, 2024
$52.28B
Oct 30, 2025
Q3
2025
Mar 31, 2024
$54.87B
May 1, 2025
Q2
2025
Dec 31, 2023
$57.44B
Jan 30, 2025
Q1
2025
Sep 30, 2023
$54.65B
Nov 1, 2024
Q3
2024
Mar 31, 2023
$50.49B
May 2, 2024
Q2
2024
Dec 31, 2022
$51.47B
Feb 1, 2024
Q1
2024
Sep 30, 2022
$49.60B
Nov 3, 2023
Q3
2023
Mar 31, 2022
$44.84B
May 4, 2023
Q2
2023
Dec 31, 2021
$45.46B
Feb 2, 2023
Q1
2023
Sep 30, 2021
$43.97B
Nov 4, 2022
Q3
2022
Mar 31, 2021
$39.28B
May 5, 2022
Q2
2022
Dec 31, 2020
$41.54B
Feb 3, 2022
Q1
2022
Sep 30, 2020
$39.07B
Nov 9, 2021
Q3
2021
Mar 31, 2020
$39.16B
May 6, 2021
Q2
2021
Dec 31, 2019
$39.74B
Feb 5, 2021
Q1
2021
Sep 30, 2019
$37.34B
Nov 5, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$467.00M
Feb 5, 2026
Q1
2026
Sep 30, 2025
$450.00M
Oct 30, 2025
Q3
2025
Mar 31, 2025
$506.00M
May 1, 2025
Q2
2026
Dec 31, 2024
$400.00M
Feb 5, 2026
Q1
2026
Sep 30, 2024
$416.00M
Oct 30, 2025
Q3
2025
Mar 31, 2024
$261.00M
May 1, 2025
Q2
2025
Dec 31, 2023
$368.00M
Jan 30, 2025
Q1
2025
Sep 30, 2023
($12.00M)
Nov 1, 2024
Q3
2024
Mar 31, 2023
$345.00M
May 2, 2024
Q2
2024
Dec 31, 2022
($130.00M)
Feb 1, 2024
Q1
2024
Sep 30, 2022
$110.00M
Nov 3, 2023
Q3
2023
Mar 31, 2022
($1.39B)
May 4, 2023
Q2
2023
Dec 31, 2021
$49.00M
Feb 2, 2023
Q1
2023
Sep 30, 2021
$271.00M
Nov 4, 2022
Q3
2022
Mar 31, 2021
$119.00M
May 5, 2022
Q2
2022
Dec 31, 2020
$629.00M
Feb 3, 2022
Q1
2022
Sep 30, 2020
($253.00M)
Nov 9, 2021
Q3
2021
Mar 31, 2020
$350.00M
May 6, 2021
Q2
2021
Dec 31, 2019
$220.00M
Feb 5, 2021
Q1
2021
Sep 30, 2019
($4.92B)
Nov 5, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$707.00M
Feb 5, 2026
Q1
2026
Sep 30, 2025
$668.00M
Oct 30, 2025
Q3
2025
Mar 31, 2025
$730.00M
May 1, 2025
Q2
2026
Dec 31, 2024
$549.00M
Feb 5, 2026
Q1
2026
Sep 30, 2024
$568.00M
Oct 30, 2025
Q3
2025
Mar 31, 2024
$369.00M
May 1, 2025
Q2
2025
Dec 31, 2023
$505.00M
Jan 30, 2025
Q1
2025
Sep 30, 2023
($32.00M)
Nov 1, 2024
Q3
2024
Mar 31, 2023
$572.00M
May 2, 2024
Q2
2024
Dec 31, 2022
($119.00M)
Feb 1, 2024
Q1
2024
Sep 30, 2022
$137.00M
Nov 3, 2023
Q3
2023
Mar 31, 2022
($97.00M)
May 4, 2023
Q2
2023
Dec 31, 2021
($950.00M)
Feb 2, 2023
Q1
2023
Sep 30, 2021
$415.00M
Nov 4, 2022
Q3
2022
Mar 31, 2021
$473.00M
May 5, 2022
Q2
2022
Dec 31, 2020
$461.00M
Feb 3, 2022
Q1
2022
Sep 30, 2020
($624.00M)
Nov 9, 2021
Q3
2021
Mar 31, 2020
$562.00M
May 6, 2021
Q2
2021
Dec 31, 2019
$334.00M
Feb 5, 2021
Q1
2021
Sep 30, 2019
($5.26B)
Nov 5, 2020